QR код

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

IntroductionScarce real-life data exists for COVID-19 management in hematologic disease (HD) patients in the Omicron era.PurposeTo assess the current clinical management and outcome of SARS-CoV-2 infection diagnosed, identify the risk factors for severe outcomes according to the HD characteristics a...

Повний опис

Збережено в:
Автори: José Luis Piñana, Lourdes Vazquez, Inmaculada Heras, Tommaso Francesco Aiello, Lucia López-Corral, Ignacio Arroyo, Eva Soler-Espejo, Irene García-Cadenas, Valentín Garcia-Gutierrez, Cristina Aroca, Pedro Chorao, María T. Olave, Javier Lopez-Jimenez, Marina Acera Gómez, Elena Arellano, Marian Cuesta-Casas, Alejandro Avendaño-Pita, Clara González-Santillana, José Ángel Hernández-Rivas, Alicia Roldán-Pérez, Mireia Mico-Cerdá, Manuel Guerreiro, Julia Morell, Paula Rodriguez-Galvez, Jorge Labrador, Diana Campos, Ángel Cedillo, Carolina Garcia Vidal, Rodrigo Martino, Carlos Solano
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2024-06-01
Серія:Frontiers in Oncology
Предмети:
SARS-CoV-2
hematologic disease
immunocompromised
risk factors
COVID - 19
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fonc.2024.1389345/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси